Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HelpScript Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
Asset Publisher
Content with Policies & Guidelines Provider-Administered Drug Claim Edit Policies .
Lupron Depot, Lupron Depot-Ped, Eligard, Fensolvi, Camcevi, Lutrate Depot™, Leuprolide Acetate Depot
Prolia, Jubbonti, Ospomyv, Stoboclo, Denosumab-dssb, Conexxence, Denosumab-bnht, Xgeva, Wyost, Xbryk, Osenvelt, Bomyntra
print
Print
Back
Back
Bortezomib*
Policy Number: PH-0351
Intravenous Only
Last Review Date:...